Ozonated Water in Treatment of Denture Stomatitis

Sponsor
National Research Centre, Egypt (Other)
Overall Status
Completed
CT.gov ID
NCT06021847
Collaborator
(none)
50
1
2
1
49.1

Study Details

Study Description

Brief Summary

The effect of Ozonated water on the treatment of oral stomatitis associated with complete denture wearer in comparison to Chlorhexidine mouthwash

Condition or Disease Intervention/Treatment Phase
  • Other: Ozonated water
  • Other: Chlorhexidine mouthwash
N/A

Detailed Description

Compete denture wearers having oral denture stomatitis were divided into two groups. group I used Ozonated water while group II used Chlorhexidine mouthwash. The growth of Candida albicans, the degree inflammation and pain grade were evaluated before starting the treatment then every week till one month. Also

Study Design

Study Type:
Interventional
Actual Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Two groups ( complete denture wearers with oral stomatitis). Group I treated with ozonated water while group II treated with chlorhexidine mouthwash.Two groups ( complete denture wearers with oral stomatitis). Group I treated with ozonated water while group II treated with chlorhexidine mouthwash.
Masking:
Single (Participant)
Masking Description:
The patients didn't know which treatment they received.
Primary Purpose:
Treatment
Official Title:
Effect of Ozone Water in Treatment of Denture Inflammation
Actual Study Start Date :
May 1, 2023
Actual Primary Completion Date :
Jun 1, 2023
Actual Study Completion Date :
Jun 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Group I patients treated with ozonated water

The patients were used ozonated water as mouth wash for treatment of denture associated oral stomatitis.

Other: Ozonated water
ozonated water was prepared with a concentration of (2-4 mg/l) ozone for 1 min. in a 25 mg of double distilled water 37o C employing an Ozone generator (Ozone generator type N 1888A, China.)

Active Comparator: Group II patients treated with chlorhexidine mouthwash

The patients were used chlorhexidine mouth wash for treatment of denture associated oral stomatitis

Other: Chlorhexidine mouthwash
Commercial available chlorhexidine mouthwash in the market was used.

Outcome Measures

Primary Outcome Measures

  1. Candida albicans colonies [day one, 7th day, 14th day and 30th day]

    The number of Candida albicans forming units (CFU) was used to assess the effect of two types of treatments.

Secondary Outcome Measures

  1. -Evaluation of inflammation and pain grade [day 1, and 30th day]

    - Evaluation of inflammation and pain grade by questionnaire

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Completely edentulous male patients wearing heat cured acrylic resin removable prosthesis.

  • Patients having denture associated oral stomatitis.

  • Healthy patients free of any systemic diseases.

Exclusion Criteria:
  • Smoker patients.

  • Patients suffering from any auto immune or systemic diseases, Temporo-mandibular joint disorder ( TMJ disorders and parafunctional oral habits.

  • Patients with a history of radiotherapy or chemotherapy.

  • Patients having oral lesions.

Contacts and Locations

Locations

Site City State Country Postal Code
1 National Research Centre Cairo Egypt 12622

Sponsors and Collaborators

  • National Research Centre, Egypt

Investigators

  • Principal Investigator: Asmaa N, Elboraey, Ass,Pro, National Research Centre, Egypt

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Asmaa Nabil Elboraey, Associate Professor of Removable Prosthodontics, National Research Centre, Egypt
ClinicalTrials.gov Identifier:
NCT06021847
Other Study ID Numbers:
  • 4447082022
First Posted:
Sep 1, 2023
Last Update Posted:
Sep 1, 2023
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Asmaa Nabil Elboraey, Associate Professor of Removable Prosthodontics, National Research Centre, Egypt
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 1, 2023